Molecular imaging in cardiovascular diseases

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 123, Issue 2, 2015, Pages

  Botnar, R M ^a   Ebersberger, H ^b,d   Noerenberg, D ^c   Jansen, C H P ^a   Wiethoff, A J ^a   Schuster, A ^a   Kasner, M ^c   Walter, T C ^c   Knobloch, G ^c   Hoppe, P ^c   Diederichs, G ^c   Hamm, B ^c   Makowski, M R ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Munich Heart Alliance   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Department of Cardiology CBF ^*  (Germany)

Author keywords

arteriosclerosis; gadolinium; MR imaging

Indexed keywords

GADOLINIUM; GADOLINIUM CHELATE; CONTRAST MEDIUM; MOLECULAR PROBE;

ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELAXATION TIME; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CEREBRAL INFARCTION; COMPUTER ASSISTED DIAGNOSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC USE; INTRACRANIAL ARTERIOSCLEROSIS; MYOCARDIAL INFARCTION; PROCEDURES; SENSITIVITY AND SPECIFICITY; ANIMAL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DISEASE MODEL; INTIMA; NEOVASCULARIZATION, PATHOLOGIC; PATHOPHYSIOLOGY;

CEREBRAL INFARCTION; CONTRAST MEDIA; CORONARY ARTERY DISEASE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INTRACRANIAL ARTERIOSCLEROSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MOLECULAR IMAGING; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR PROBES; NEOVASCULARIZATION, PATHOLOGIC; TUNICA INTIMA;

EID: 84921283211     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0034-1385451     Document Type: Review

References (66)

1. Roger V. L., Go A. S., Lloyd-Jones D. M. et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation: 2011; 123 e18 e209
2. Ambrose J. A., Tannenbaum M. A., Alexopoulos D. et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol: 1988; 12 56 62
3. Burke A. P., Kolodgie F. D., Farb A. et al. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation: 2002; 105 297 303
4. Varnava A. M., Mills P. G., Davies M. J. Relationship between coronary artery remodeling and plaque vulnerability. Circulation: 2002; 105 939 943
5. Glagov S., Weisenberg E., Zarins C. K. et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med: 1987; 316 1371 1375
6. Rentrop K. P. Thrombi in acute coronary syndromes: revisited and revised. Circulation: 2000; 101 1619 1626
7. Botnar R. M., Stuber M., Kissinger K. V. et al. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation: 2000; 102 2582 2587
8. Fayad Z. A., Fuster V., Fallon J. T. et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation: 2000; 102 506 510
9. Corti R., Fuster V., Fayad Z. A. et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol: 2005; 46 106 112
10. Ibrahim T., Makowski M. R., Jankauskas A. et al. Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. JACC Cardiovasc Imaging: 2009; 2 580 588
11. Gore J. C., Yankeelov T. E., Peterson T. E. et al. Molecular imaging without radiopharmaceuticals? Journal of nuclear medicine: official publication, Society of Nuclear Medicine: 2009; 50 999 1007
12. Sato Y., Hatakeyama K., Marutsuka K. et al. Incidence of asymptomatic coronary thrombosis and plaque disruption: comparison of non-cardiac and cardiac deaths among autopsy cases. Thromb Res: 2009; 124 19 23
13. Libby P., Ridker P. M., Hansson Gr K. Progress and challenges in translating the biology of atherosclerosis. Nature: 2011; 473 317 325
14. Krettek A., Sukhova G. K., Libby P. Elastogenesis in human arterial disease: a role for macrophages in disordered elastin synthesis. Arterioscler Thromb Vasc Biol: 2003; 23 582 587
15. Kolodgie F. D., Narula J., Yuan C. et al. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? Journal of the American College of Cardiology: 2007; 49 2093 2101
16. Kolodgie F. D., Gold H. K., Burke A. P. et al. Intraplaque hemorrhage and progression of coronary atheroma. The New England journal of medicine: 2003; 349 2316 2325
17. Narula J., Garg P., Achenbach S. et al. Arithmetic of vulnerable plaques for noninvasive imaging. Nature Clinical Practice Cardiovascular Medicine: 2008; 5 S2 S10
18. Stone G. W., Maehara A., Lansky A. J. et al. A prospective natural-history study of coronary atherosclerosis. The New England journal of medicine: 2011; 364 226 235
19. Burke A. P., Farb A., Malcom G. T. et al. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation: 1998; 97 2110 2116
20. Johnson R. C., Leopold J. A., Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res: 2006; 99 1044 1059
21. Aikawa E., Nahrendorf M., Figueiredo J. L. et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation: 2007; 116 2841 2850
22. Proudfoot D., Skepper J. N., Hegyi L. et al. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res: 2000; 87 1055 1062
23. Tyson K. L., Reynolds J. L., McNair R. et al. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arteriosclerosis, thrombosis, and vascular biology: 2003; 23 489 494
24. Virmani R., Ladich E. R., Burke A. P. et al. Histopathology of carotid atherosclerotic disease. Neurosurgery: 2006; 59 S219 S227
25. Johnson G. A., Benveniste H., Black R. D. et al. Histology by magnetic resonance microscopy. Magn Reson Q: 1993; 9 1 30
26. Schmitz S. A., Coupland S. E., Gust R. et al. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol: 2000; 35 460 471
27. Caravan P., Ellison J. J., McMurry T. J. et al. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem Rev: 1999; 99 2293 2352
28. Weinmann H. J., Brasch R. C., Press W. R. et al. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol Am J Roentgenol: 1984; 142 619 624
29. Nazarpoor M. Effects of inversion and saturation times on relationships between contrast agent concentrations and signal intensities of T1-weighted magnetic resonance images. Radiol Phys Technol: 2010; 3 120 126
30. Mugler J. P. 3rd, Brookeman J. R. Theoretical analysis of gadopentetate dimeglumine enhancement in T1-weighted imaging of the brain: comparison of two-dimensional spin-echo and three-dimensional gradient-echo sequences. J Magn Reson Imaging: 1993; 3 761 769
31. Kok M., Hak S., Mulder W. et al. Cellular compartmentalization of internalized paramagnetic liposomes strongly influences both T 1and T 2relaxivity. Magnetic Resonance in Medicine: 2009; 61 1022 1032
32. Caravan P., Farrar C. T., Frullano L. et al. Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents. Contrast Media Mol Imaging: 2009; 4 89 100
33. Nivorozhkin A. L., Kolodziej A. F., Caravan P. et al. Enzyme-Activated Gd(3+) Magnetic Resonance Imaging Contrast Agents with a Prominent Receptor-Induced Magnetization Enhancement. Angew Chem Int Ed Engl: 2001; 40 2903 2906
34. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chemical Society Reviews: 2006; 35 512
35. Botnar R. M., Buecker A., Wiethoff A. J. et al. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation: 2004; 110 1463 1466
36. Flacke S., Fischer S., Scott M. J. et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation: 2001; 104 1280 1285
37. Winter P. M., Morawski A. M., Caruthers S. D. et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation: 2003; 108 2270 2274
38. Weissleder R., Elizondo G., Wittenberg J. et al. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology: 1990; 175 489 493
39. Farrar C. T., Dai G., Novikov M. et al. Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging. NMR Biomed: 2008; 21 453 463
40. Ferrucci J. T., Stark D. D. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. Am J Roentgenol Am J Roentgenol: 1990; 155 943 950
41. Small W. C., Nelson R. C., Bernardino M. E. Dual contrast enhancement of both T1- and T2-weighted sequences using ultrasmall superparamagnetic iron oxide. Magn Reson Imaging: 1993; 11 645 654
42. Makowski M. R., Wiethoff A. J., Blume U. et al. Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med: 2011; 17 383 388
43. Makowski M. R., Varma G., Wiethoff A. et al. Non-Invasive Assessment of Atherosclerotic Plaque Progression in ApoE-/- Mice Using Susceptibility Gradient Mapping. Circ Cardiovasc Imaging: 2011; 10.1161/CIRCIMAGING.110.957209
44. von Bary C., Makowski M., Preissel A. et al. MRI of Coronary Wall Remodeling in a Swine Model of Coronary Injury Using an Elastin-Binding Contrast Agent. Circ Cardiovasc Imaging: 2011; 4 147 155
45. Meding J., Urich M., Licha K. et al. Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with gadofluorine M. Contrast Media Mol Imaging: 2007; 2 120 129
46. Sirol M., Itskovich V. V., Mani V. et al. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation: 2004; 109 2890 2896
47. Sirol M., Moreno P., Purushothaman K. et al. Increased Neovascularization in Advanced Lipid-Rich Atherosclerotic Lesions Detected by Gadofluorine-M-Enhanced MRI: Implications for Plaque Vulnerability. Circulation: Cardiovascular Imaging: 2009; 2 391 396
48. Ronald J. A., Chen Y., Belisle A. J. et al. Comparison of gadofluorine-M and Gd-DTPA for noninvasive staging of atherosclerotic plaque stability using MRI. Circ Cardiovasc Imaging: 2009; 2 226 234
49. Tavora F., Cresswell N., Li L. et al. Immunolocalisation of fibrin in coronary atherosclerosis: implications for necrotic core development. Pathology: 2010; 42 15 22
50. Botnar R. M., Perez A. S., Witte S. et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation: 2004; 109 2023 2029
51. Spuentrup E., Buecker A., Katoh M. et al. Molecular Magnetic Resonance Imaging of Coronary Thrombosis and Pulmonary Emboli With a Novel Fibrin-Targeted Contrast Agent. Circulation: 2005; 112 1594 1600
52. Spuentrup E., Botnar R. M., Wiethoff A. et al. MR imaging of thrombi using EP-2104R, a fibrin specific contrast agent: initial results in patients. European Radiology: 2008; 18 1995 2005
53. Cybulsky M. I., Gimbrone M. A. Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science: 1991; 251 788 791
54. Nahrendorf M., Jaffer F., Kelly K. et al. Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis. Circulation: 2006; 114 1504 1511
55. Kooi M. E., Cappendijk V. C., Cleutjens K. B. et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation: 2003; 107 2453 2458
56. Ruehm S. G., Corot C., Vogt P. et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation: 2001; 103 415 422
57. Schmitz S. A., Coupland S. E., Gust R. et al. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Investigative radiology: 2000; 35 460 471
58. Morishige K., Kacher D. F., Libby P. et al. High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis. Circulation: 2010; 122 1707 1715
59. Korosoglou G., Weiss R. G., Kedziorek D. A. et al. Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. Journal of the American College of Cardiology: 2008; 52 483 491
60. Mani V., Briley-Saebo K. C., Itskovich V. V. et al. Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn Reson Med: 2006; 55 126 135
61. Amirbekian V., Lipinski M. J., Briley-Saebo K. C. et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci U S A: 2007; 104 961 966
62. Frias J. C., Ma Y., Williams K. J. et al. Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging. Nano Lett: 2006; 6 2220 2224
63. Cormode D. P., Briley-Saebo K. C., Mulder W. J. et al. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection. Small: 2008; 4 1437 1444
64. Chen W., Vucic E., Leupold E. et al. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis. Contrast Media Mol Imaging: 2008; 3 233 242
65. Purushothaman K. R., Sanz J., Zias E. et al. Atherosclerosis neovascularization and imaging. Curr Mol Med: 2006; 6 549 556
66. Kerwin W. S., O'Brien K. D., Ferguson M. S. et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology: 2006; 241 459 468